- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04535258
Blended Treatment for Alcohol Use Disorder (BLEND-A)
Blended Treatment for Alcohol Use Disorder - The BLEND-A Study Evaluation of a Blended Treatment Intervention for Alcohol Use Disorder in Denmark
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Background: A major challenge to psychological treatment for Alcohol Use Disorder (AUD) is patient non-compliance. A promising new treatment approach that is hypothesized to increase treatment compliance is blended treatment, consisting of face-to-face contact with a therapist combined with modules delivered over the Internet within the same protocol. While this treatment concept has been developed and proven effective for a variety of mental disorders, it has not yet been examined for AUD.
Aims: The study described in this protocol aims to examine and evaluate patient compliance with blended AUD treatment as well as the clinical and cost effectiveness of such treatment compared to face-to-face treatment only.
Methods: The study design is a pragmatic, stepped-wedge cluster randomized controlled trial. The included outpatient institutions (planned number of patients: n=1800) will be randomized in clusters to implement either blended AUD treatment or face-to-face treatment only, i.e. treatment as usual (TAU). Both treatment approaches consist of motivational interviewing and cognitive behavioral therapy. Data on socio-demographics, alcohol consumption, addiction severity, treatment retention, treatment duration and intensity, and type of conclusion of treatment (dropout vs. compliance), will be retrieved from the National Register of Alcohol Treatment (NAB). In addition, all patients will be assessed for alcohol consumption, consequences of drinking and quality of life at treatment entry and six months after treatment conclusion. Data will be analyzed with an Intention-to-treat approach by means of generalized mixed models with random effect for cluster and fixed effect for each step. Also, analyses evaluating cost-effectiveness will be conducted.
Discussion: Blended treatment may increase treatment compliance and thus improve treatment outcomes due to increased flexibility of the treatment course. Since this study is conducted within an implementation framework it can easily be scaled up, and blended treatment has the potential to become an alternative offer in the majority ofmany outpatient clinics nationwide.
Studientyp
Einschreibung (Voraussichtlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Odense, Dänemark, 5000
- Unit if Clinical Alcohol Research
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Legal person seeking public alcohol treatment in the participating municipalities.
Exclusion Criteria:
- None.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Sonstiges: First-movers
The first four alcohol clinics offers internet-based treatment to the patients who chooses the proportion of internet-based sessions.
|
Treatment for alcohol use disorders will be offered also as an internet-based option.
|
Sonstiges: Second-movers
After three months, the next five alcohol clinics offers internet-based treatment to the patients who chooses the proportion of internet-based sessions.
|
Treatment for alcohol use disorders will be offered also as an internet-based option.
|
Sonstiges: Third-movers
After three months, the next five alcohol clinics offers internet-based treatment to the patients who chooses the proportion of internet-based sessions.
|
Treatment for alcohol use disorders will be offered also as an internet-based option.
|
Sonstiges: Fourth-movers
After three months, the last four alcohol clinics offers internet-based treatment to the patients who chooses the proportion of internet-based sessions.
|
Treatment for alcohol use disorders will be offered also as an internet-based option.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Compliance and premature dropout in alcohol treatment
Zeitfenster: One year after enrolled in the study
|
BLEND-A (outpatient treatment as usual offered as a combination between face-to face and internet-based sessions) leads to a change in compliance in treatment during one year following initiation of treatment, compared to TAU (usual treatment delivered as face-to-face outpatient treatment only ), and measured as a change in premature dropout of treatment in the National Register of alcohol treatment (NAB).
|
One year after enrolled in the study
|
Effectiveness of alcohol treatment
Zeitfenster: 6 months after enrolled in the study
|
The effectiveness of BLEND-A compared to TAU, measured by alcohol intake 6 months after treatment start.
The alcohol intake is measured by self-reported alcohol intake.
|
6 months after enrolled in the study
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Differences in Quality of Life according to the intervention
Zeitfenster: 6 months after enrolled in the study
|
BLEND-A leads to a change in quality of life (measured by means of Patient Reported Outcomes (PRO)) among patients, compared to face-to-face outpatient treatment as usual, measured 6 months after treatment start.
|
6 months after enrolled in the study
|
Which part of treatment is appreciated to receive via the internet
Zeitfenster: Through study completion, an average of 1 year
|
Based on the user data from BLEND-A, we expect to be able to determine what part of the usual treatment that is appreciated to receive via the internet.
|
Through study completion, an average of 1 year
|
Optimal blend
Zeitfenster: Through study completion, an average of 1 year
|
Based on the user data from BLEND-A, we expect to be able to determine the optimal combination of face-to-face and internet-based sessions.
|
Through study completion, an average of 1 year
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Qualitative interviews
Zeitfenster: Through study completion, an average of 1 year
|
The perspectives for further refinement of BLEND-A will be assessed by qualitative interviews with patients and therapists receiving or delivering the intervention.
|
Through study completion, an average of 1 year
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Studienleiter: Anette S. Nielsen, PhD, University of Southern Denmark
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- BLEND-A
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Alkoholkonsumstörung
-
University of KonstanzAfrica Mental Health FoundationAbgeschlossenKhat-Use-StörungKenia
-
University of North Carolina, Chapel HillRekrutierungOff-Label-Use von Medikamenten bei pädiatrischen PatientenVereinigte Staaten
-
University of Massachusetts, WorcesterAgency for Healthcare Research and Quality (AHRQ); Omnicare Clinical Research; Qualidig...AbgeschlossenOff-Label-Use von atypischen AntipsychotikaVereinigte Staaten
-
University of KonstanzAfrica Mental Health FoundationAbgeschlossenPosttraumatische Belastungsstörung | Khat-Use-StörungKenia
Klinische Studien zur Blend-A
-
Mednax Center for Research, Education, Quality...Phoenix Children's Hospital; Banner University Medical CenterAbgeschlossenVollständige parenterale Ernährung | Nekrotisierende Enterokolitis des NeugeborenenVereinigte Staaten
-
Miami Research AssociatesGlanbia Performance NutritionAbgeschlossen
-
CherryPharmAbgeschlossenArthroseVereinigte Staaten
-
Massachusetts General HospitalNational Cancer Institute (NCI); National Institutes of Health (NIH)RekrutierungDarmkrebs | Fibrose, Leber | Stenose | Magen-Darm-Mikrobiom | Kaffee | Ultraschall-Elastographie | Protonen-MagnetresonanzspektroskopieVereinigte Staaten
-
University of California, Los AngelesAbgeschlossenPrädiabetischer ZustandVereinigte Staaten
-
Johnson & Johnson Vision Care, Inc.Abgeschlossen
-
Johnson & Johnson Vision Care, Inc.AbgeschlossenHornhautinfiltrative Ereignisse | HornhautentzündungVereinigte Staaten
-
Coopervision, Inc.Abgeschlossen
-
Johnson & Johnson Vision Care, Inc.Abgeschlossen
-
Coopervision, Inc.Abgeschlossen